Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -24.14% vs 1.14% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -29.57% vs 155.56% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -42.38% vs -0.44% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -5.09% vs 4.35% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -30.07% vs 17.26% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -24.14% vs 1.14% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 52.83% vs -54.31% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -29.57% vs 155.56% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -41.35% vs -8.25% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -42.38% vs -0.44% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.49% vs 2.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -5.09% vs 4.35% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






